|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
DE3169595D1
(en)
|
1980-11-10 |
1985-05-02 |
Gersonde Klaus |
Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
DE3374837D1
(en)
|
1982-02-17 |
1988-01-21 |
Ciba Geigy Ag |
Lipids in the aqueous phase
|
|
DE3218121A1
(de)
|
1982-05-14 |
1983-11-17 |
Leskovar, Peter, Dr.-Ing., 8000 München |
Arzneimittel zur tumorbehandlung
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
JPS607934A
(ja)
|
1983-06-29 |
1985-01-16 |
Dai Ichi Seiyaku Co Ltd |
リポソ−ムの製造方法
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
ATE159858T1
(de)
|
1983-09-26 |
1997-11-15 |
Ehrenfeld Udo |
Mittel und erzeugnis für die diagnose und therapie von tumoren sowie zur behandlung von schwächen der zelligen und humoralen immunabwehr
|
|
US4615885A
(en)
|
1983-11-01 |
1986-10-07 |
Terumo Kabushiki Kaisha |
Pharmaceutical composition containing urokinase
|
|
WO1989001489A1
(en)
|
1987-08-10 |
1989-02-23 |
Commonwealth Scientific And Industrial Research Or |
Control of angiogenesis and compositions and methods therefor
|
|
SE463851B
(sv)
|
1988-09-02 |
1991-02-04 |
Amsu Ltd |
Komposition foer behandling av erektil dysfunktion via uretra
|
|
US5530109A
(en)
|
1991-04-10 |
1996-06-25 |
Ludwig Institute For Cancer Research |
DNA encoding glial mitogenic factors
|
|
US5716930A
(en)
|
1991-04-10 |
1998-02-10 |
Ludwig Institute For Cancer Research |
Glial growth factors
|
|
GB9107566D0
(en)
|
1991-04-10 |
1991-05-29 |
Ludwig Inst Cancer Res |
Glial mitogenic factors,their preparation and use
|
|
US7115554B1
(en)
|
1993-05-06 |
2006-10-03 |
Acorda Therapeutics, Inc. |
Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
|
|
US5834229A
(en)
|
1991-05-24 |
1998-11-10 |
Genentech, Inc. |
Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
|
|
US6087323A
(en)
|
1992-04-03 |
2000-07-11 |
Cambridge Neuroscience, Inc. |
Use of neuregulins as modulators of cellular communication
|
|
DE4221256C2
(de)
|
1992-06-26 |
1997-07-10 |
Lancaster Group Ag |
Galenische Zusammensetzung für die topische Anwendung
|
|
EP0647449A1
(en)
|
1993-06-24 |
1995-04-12 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation of anti-endothelin substance
|
|
US6750196B1
(en)
|
1995-03-27 |
2004-06-15 |
Acorda Therapeutics |
Methods of treating disorders of the eye
|
|
US5741511A
(en)
|
1995-04-12 |
1998-04-21 |
Sam Yang Co., Ltd. |
Transdermal drug delivery device for treating erectile dysfunction
|
|
US5912326A
(en)
|
1995-09-08 |
1999-06-15 |
President And Fellows Of Harvard College |
Cerebellum-derived growth factors
|
|
WO1997023256A1
(en)
|
1995-12-22 |
1997-07-03 |
Localmed, Inc. |
Localized intravascular delivery of growth factors for promotion of angiogenesis
|
|
US5736154A
(en)
|
1996-03-11 |
1998-04-07 |
Fuisz Technologies Ltd. |
Transdermal delivery system
|
|
DE69840699D1
(de)
|
1997-02-10 |
2009-05-14 |
Genentech Inc |
Heregulin varianten
|
|
SE9703226D0
(sv)
|
1997-09-08 |
1997-09-08 |
Astra Ab |
New pharmaceutical composition
|
|
EP1028735A4
(en)
|
1997-10-14 |
2003-08-06 |
Cenes Pharmaceuticals Inc |
THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN
|
|
US6197801B1
(en)
|
1998-01-14 |
2001-03-06 |
Usa Doctors Products, Inc. |
Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction
|
|
AUPP785098A0
(en)
|
1998-12-21 |
1999-01-21 |
Victor Chang Cardiac Research Institute, The |
Treatment of heart disease
|
|
US6635249B1
(en)
|
1999-04-23 |
2003-10-21 |
Cenes Pharmaceuticals, Inc. |
Methods for treating congestive heart failure
|
|
CN1138785C
(zh)
|
1999-06-04 |
2004-02-18 |
周明东 |
生长因子神经调节蛋白及其类似物的新应用
|
|
AUPQ105799A0
(en)
|
1999-06-18 |
1999-07-08 |
Victor Chang Cardiac Research Institute, The |
Cell growth inhibition
|
|
CA2400595A1
(en)
|
2000-02-28 |
2001-09-07 |
Decode Genetics Ehf |
Human schizophrenia gene
|
|
US20010041869A1
(en)
|
2000-03-23 |
2001-11-15 |
Causey James D. |
Control tabs for infusion devices and methods of using the same
|
|
US20050277887A1
(en)
*
|
2000-05-08 |
2005-12-15 |
Joel Douglas |
Micro infusion drug delivery device
|
|
ES2610353T3
(es)
|
2000-05-23 |
2017-04-27 |
Cenes Pharmaceuticals, Inc. |
Moléculas de ácido nucleico NRG-2, polipéptidos y métodos diagnósticos y terapéuticos
|
|
US6589229B1
(en)
|
2000-07-31 |
2003-07-08 |
Becton, Dickinson And Company |
Wearable, self-contained drug infusion device
|
|
AU2001290864A1
(en)
|
2000-09-12 |
2002-04-02 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Optimized cardiac contraction through differential phosphorylation of myosin
|
|
US6482624B2
(en)
|
2000-11-14 |
2002-11-19 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
WO2002048191A2
(en)
|
2000-12-11 |
2002-06-20 |
Yeda Research And Development Co. Ltd. |
Inhibitory agents derived from specific growth factors
|
|
RU2180843C1
(ru)
|
2001-02-19 |
2002-03-27 |
Новокузнецкий государственный институт усовершенствования врачей |
Способ профилактики повторного инфаркта миокарда
|
|
CA2448320A1
(en)
*
|
2001-05-29 |
2002-12-05 |
Sirna Therapeutics, Inc. |
Ribozyme based treatment of female reproductive diseases
|
|
IL160928A0
(en)
|
2001-10-19 |
2004-08-31 |
Maxim Pharm Inc |
Use of histamine to treat liver disease
|
|
CN1498656A
(zh)
|
2002-11-08 |
2004-05-26 |
上海泽生科技开发有限公司 |
神经调节蛋白用于心肌梗死治疗的方法和组合物
|
|
AU2002304965A1
(en)
|
2002-05-24 |
2003-12-12 |
Zensun (Shanghai) Sci-Tech.Ltd |
Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
|
|
US7144384B2
(en)
|
2002-09-30 |
2006-12-05 |
Insulet Corporation |
Dispenser components and methods for patient infusion device
|
|
US7128727B2
(en)
|
2002-09-30 |
2006-10-31 |
Flaherty J Christopher |
Components and methods for patient infusion device
|
|
AU2003293124A1
(en)
|
2002-11-27 |
2004-06-23 |
Artesian Therapeutics, Inc. |
Heart failure gene determination and therapeutic screening
|
|
MXPA05012619A
(es)
|
2003-05-21 |
2006-02-08 |
Univ Texas |
Inhibicion de la proteina cinasa c-mu como un tratamiento para la hipertrofia cardiaca y la falla cardiaca.
|
|
US20050065760A1
(en)
|
2003-09-23 |
2005-03-24 |
Robert Murtfeldt |
Method for advising patients concerning doses of insulin
|
|
CN1715926B
(zh)
|
2004-07-02 |
2011-08-17 |
上海泽生科技开发有限公司 |
神经调节蛋白突变体的应用
|
|
CN1743006A
(zh)
|
2004-09-02 |
2006-03-08 |
上海泽生科技开发有限公司 |
Mapk抑制剂的新用途及组合物
|
|
CN1743005A
(zh)
|
2004-09-02 |
2006-03-08 |
上海泽生科技开发有限公司 |
Pi3－k抑制剂的新用途及组合物
|
|
CA2583972A1
(en)
|
2004-10-14 |
2006-10-19 |
Adventures Plus Pty Ltd |
A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
|
|
US20060160062A1
(en)
|
2005-01-14 |
2006-07-20 |
Young Lindon H |
Perfusion and/or preservation solution for organs
|
|
US20070141548A1
(en)
|
2005-03-11 |
2007-06-21 |
Jorg Kohl |
Organ transplant solutions and method for transplanting organs
|
|
US7569050B2
(en)
|
2005-05-06 |
2009-08-04 |
Medtronic Minimed, Inc. |
Infusion device and method with drive device in infusion device and method with drive device in separable durable housing portion
|
|
CN100361709C
(zh)
|
2005-08-30 |
2008-01-16 |
山东省生物药物研究院 |
一种对生命活性物质有保护作用的糖类组合
|
|
CN1768859A
(zh)
|
2005-10-24 |
2006-05-10 |
天津大学 |
基于醛基的微粒表面多重生物功能因子组装方法
|
|
US20070213264A1
(en)
|
2005-12-02 |
2007-09-13 |
Mingdong Zhou |
Neuregulin variants and methods of screening and using thereof
|
|
JP5738516B2
(ja)
*
|
2005-12-30 |
2015-06-24 |
ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド |
心機能改善のためのニューレグリンの徐放
|
|
CN101394861A
(zh)
*
|
2005-12-30 |
2009-03-25 |
上海泽生科技开发有限公司 |
纽兰格林持续给药能改善心脏功能
|
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
|
CN101310766B
(zh)
|
2007-05-25 |
2014-04-16 |
上海泽生科技开发有限公司 |
神经调节蛋白的新用途
|
|
CN101310779A
(zh)
*
|
2007-05-25 |
2008-11-26 |
上海泽生科技开发有限公司 |
包含神经调节蛋白的装置及药物制剂
|
|
US20090156488A1
(en)
|
2007-09-12 |
2009-06-18 |
Zensun (Shanghai) Science & Technology Limited |
Use of neuregulin for organ preservation
|
|
US20110166068A1
(en)
|
2008-07-17 |
2011-07-07 |
Acorda Therapeutics, Inc. |
Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart Failure
|
|
EP2808339B1
(en)
|
2008-11-28 |
2017-02-15 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neuregulin peptides and their use
|
|
WO2010060266A1
(en)
|
2008-11-28 |
2010-06-03 |
Zensun (Shanghai) Science & Technology Limited |
Neuregulin and cardiac stem cells
|
|
WO2010142141A1
(en)
*
|
2009-06-09 |
2010-12-16 |
Zensun (Shanghai) Science & Technology Limited |
Neuregulin based methods for treating heart failure
|
|
CN102470161A
(zh)
*
|
2009-06-09 |
2012-05-23 |
上海泽生科技开发有限公司 |
神经调节蛋白用于治疗心力衰竭的有效剂量
|
|
JP6096262B2
(ja)
|
2009-08-25 |
2017-03-15 |
ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． |
ニューレグリンに基づく心不全の治療方法
|
|
CN102139095A
(zh)
|
2010-01-29 |
2011-08-03 |
上海泽生科技开发有限公司 |
神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
|
|
US20130053318A1
(en)
*
|
2010-03-10 |
2013-02-28 |
Parry Laura |
Modulating aquaporins with relaxin
|
|
US20130045937A1
(en)
|
2010-03-10 |
2013-02-21 |
Cempra Pharmaceuticals, Inc. |
Parenteral formulations of macrolide antibiotics
|
|
US9029328B2
(en)
|
2010-03-24 |
2015-05-12 |
The Brigham And Women's Hospital, Inc. |
Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands
|
|
JP2013532661A
(ja)
|
2010-07-22 |
2013-08-19 |
リベン ファーマシューティカルズ インコーポレイテッド |
磁気双極子安定化溶液の使用を含む疾患を処置または改善する方法および行動を向上させる方法
|
|
WO2013053076A1
(en)
|
2011-10-10 |
2013-04-18 |
Zensun （Shanghai）Science & Technology Limited |
Compositions and methods for treating heart failure
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
BR112015006656A8
(pt)
|
2012-10-08 |
2020-01-21 |
Sensun Shanghai Science & Tech Co Ltd |
composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
|
|
US20160129084A1
(en)
|
2013-03-06 |
2016-05-12 |
Acorda Therapeutics, Inc. |
Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart Failure
|
|
EP2999499B1
(en)
|
2013-05-22 |
2019-07-17 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Extended release of neuregulin for treating heart failure
|
|
CN104337813A
(zh)
|
2013-07-23 |
2015-02-11 |
上海泽生科技开发有限公司 |
使用维生素b组合物促进胃肠系统动力的方法
|
|
CN104758300A
(zh)
|
2014-01-02 |
2015-07-08 |
上海泽生科技开发有限公司 |
维生素d及其组合物的抗菌用途
|
|
CN104758922A
(zh)
|
2014-01-03 |
2015-07-08 |
上海泽生科技开发有限公司 |
纽兰格林制剂的配方
|
|
CN105497876B
(zh)
|
2014-09-24 |
2021-01-15 |
上海泽生科技开发股份有限公司 |
神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
|
|
CN111407882A
(zh)
|
2014-10-17 |
2020-07-14 |
上海泽生科技开发股份有限公司 |
神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
|
|
AT521173B1
(de)
|
2018-06-27 |
2019-11-15 |
Trumpf Maschinen Austria Gmbh & Co Kg |
Biegewerkzeug mit Distanzelement
|